Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2372942 | 1.00 | CYP1A2 (0.46) | CYP1A2CYP2D6MAPTKMT2AKCNN4 | |
| SCHEMBL2371928 | 1.00 | CYP1A2 (0.46) | CYP1A2CYP2D6MAPTKMT2AKCNN4 | |
| SCHEMBL2208136 | 0.85 | CYP1A2 (0.54) | CYP1A2CYP2D6MAPTKMT2AKCNN4 | |
| SCHEMBL6998732 | 0.83 | CYP1A2 (0.43) | CYP1A2CYP2D6MAPTKMT2AKCNN4 | |
| SCHEMBL10569602 | 0.83 | CYP1A2 (0.43) | CYP1A2CYP2D6MAPTKMT2AKCNN4 | |
| Acetamide SCHEMBL11005368 | 0.81 | MAPT (0.53) | CYP1A2CYP2D6MAPTKMT2AKCNN4 | |
| SCHEMBL7782499 | 0.81 | CES1 (0.52) | CYP1A2MAPTKMT2AKCNN4CYP2C19 | |
| SCHEMBL12083438 | 0.79 | KCNN4 (0.60) | MAPTKMT2AKCNN4HDAC3HDAC4 | |
| Methylamine SCHEMBL11005397 | 0.78 | MAPT (0.55) | CYP1A2CYP2D6MAPTKMT2AKCNN4 | |
| SCHEMBL10810428 | 0.78 | HDAC3 (0.43) | CYP1A2CYP2D6MAPTKMT2AKCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250230160-A1 | PROCESS FOR THE PREPARATION OF 4-((6BR,10AS)-3-METHYL-2,3,6B,9,10,10A-HEXAHYDRO-1H,7H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALIN-8-YL)-1-(4-FLUORO-PHENYL)-BUTAN-1-ONE AND INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2025-07-17 | — | — | US | claimed |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-03-27 | — | — | US | claimed |
| CN-118021632-A | Composition for promoting differentiation or proliferation of human adipose-derived stem cells | 株式会社LG生活健康 | 2024-05-14 | — | — | CN | claimed |
| WO-2023195027-A1 | PROCESS FOR THE PREPARATION OF 4-((6BR,10AS)-3-METHYL-2,3,6B,9,10,10A-HEXAHYDRO-1H,7H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALIN-8-YL)-1-(4-FLUORO-PHENYL)-BUTAN-1-ONE AND INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2023-10-12 | — | — | WO | claimed |
| EP-4253366-A2 | METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION | Gilead Sciences, Inc. (US) | 2023-10-04 | — | — | EP | claimed |
| US-11760746-B2 | Methods and intermediates for preparing therapeutic compounds | GILEAD SCIENCES, INC. (US) | 2023-09-19 | — | — | US | claimed |
| CN-112055712-B | Methods and intermediates for preparing therapeutic compounds useful in the treatment of retroviral infections | 吉利德科学公司 | 2023-07-14 | — | — | CN | claimed |
| EP-3610865-B1 | COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT | AMOREPACIFIC CORP (KR) | 2023-07-12 | — | — | EP | claimed |
| EP-3752496-B1 | METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION | GILEAD SCIENCES INC (US) | 2023-07-05 | — | — | EP | claimed |
| US-11673071-B2 | Isotopic compositions | BOTANICAL WATER TECHNOLOGIES IP LTD (GB) | 2023-06-13 | — | — | US | claimed |
| US-9468278-B2 | Hair colouring methods and kits thereof | THE PROCTER & GAMBLE COMPANY (US) | 2016-10-18 | — | — | US | claimed |
| EP-3036009-A1 | HAIR COLOURING METHODS AND KITS THEREOF | The Procter & Gamble Company (US) | 2016-06-29 | — | — | EP | claimed |
| US-9358201-B2 | Hair colouring methods and kits thereof | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-07 | — | — | US | claimed |
| EP-2881143-A2 | Hair colouring methods and kits thereof | The Procter and Gamble Company (US) | 2015-06-10 | — | — | EP | claimed |
| US-20150053228-A1 | Hair Colouring Methods and Kits Thereof | WELLA OPERATIONS US, LLC | 2015-02-26 | — | — | US | claimed |
| WO-2015026991-A2 | HAIR COLOURING METHODS AND KITS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2015-02-26 | — | — | WO | claimed |
| WO-2015026994-A1 | HAIR COLOURING METHODS AND KITS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2015-02-26 | — | — | WO | claimed |
| US-20150053230-A1 | Hair Colouring Methods and Kits Thereof | WELLA OPERATIONS US, LLC | 2015-02-26 | — | — | US | claimed |
| CN-101613666-B | Bacillus and application thereof | UNIV EAST CHINA SCIENCE & TECH | 2011-01-19 | — | — | CN | claimed |
| CN-101613666-A | One bacillus and purposes | UNIV EAST CHINA SCIENCE & TECH | 2009-12-30 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150053228-A1 | Hair Colouring Methods and Kits Thereof | COXFA4L2, ALPG, NACA | CYP1A2 841/4885CYP2D6 923/4885MAPT 2094/4885 |
| US-20250230160-A1 | PROCESS FOR THE PREPARATION OF 4-((6BR,10AS)-3-METHYL-2,3,6B,9,10,10A-HEXAHYDRO-1H,7H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALIN-8-YL)-1-(4-FLUORO-PHENYL)-BUTAN-1-ONE AND INTERMEDIATES THEREOF | CYP1B1, CYP4B1, CYP7A1 | CYP1A2 20/4885CYP2D6 8/4885MAPT 3086/4885 |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | CYP11A1, CYP11B1, CYP11B2 | CYP1A2 515/4885CYP2D6 71/4885MAPT 1009/4885 |
| US-11760746-B2 | Methods and intermediates for preparing therapeutic compounds | CYP11A1, CYP11B1, CYP11B2 | CYP1A2 525/4885CYP2D6 82/4885MAPT 1035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.